Learning, Inspiring, Sharing
Efficient Ultrasound Neuromodulation Optimization
Includes a Live Web Event on 10/20/2026 at 1:00 PM (EDT)
Needs Assessment
Professional practice gaps were identified through publications and discussions at recent scientific conferences in the use of control conditions in ultrasound neuromodulation, high inter-and intra-subject variability in ultrasound neuromodulation responses and the need for personalization.
In this webinar, we will first introduce some of the major challenges in ultrasound neuromodulation. Then, I will discuss a data-driven method that we have recently developed for closed-loop optimization of ultrasound neuromodulation parameters.
Reference(s):
1: https://pmc.ncbi.nlm.nih.gov/a...
2: https://pubmed.ncbi.nlm.nih.go...
Learning Objectives:
After participating in this activity, learners should be able to:
- Identify current challenges and limitations in ultrasound neuromodulation in humans and rodents.
- Discuss technological strategies to improve the efficacy and reliability of ultrasound neuromodulation studies.
Target Audience:
This webinar is designed to meet the needs of neuroradiologists, psychiatrists, as well as other clinicians with an interest in ultrasound neuromodulation imaging.
Faculty:
Tommaso Di Ianni, PhD, Assistant Professor, Director, Basic Ultrasound Research, Program Co-Director, Focused Ultrasound in Neuroscience Program Department of Psychiatry and Behavioral Sciences Department of Radiology and Biomedical Imaging Weill Institute for Neurosciences, University of California, San Francisco
Available Credit: 1 AMA PRA Category 1 Credit(s)™/1 ARRT Category A credit(s). Upon completion of the learning activity, you will have 2 attempts to successfully pass the post-test with a score of at least 80% and claim your certificate.
AIUM Member: $0
Nonmember: $19
Join the AIUM today to access and earn for free.
Your fee includes access to the content and the opportunity to submit the CME test.
Key:
Estimated time to complete activity: 1 hour
ACCME Accreditation
The American Institute of Ultrasound in Medicine (AIUM) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
AMA PRA Category 1 Credit(s)™
The AIUM designates this internet enduring material for a maximum of 1 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
AIUM Ultrasound Practice Accreditation
This activity can be used to meet part of relevant AIUM Training Guidelines and/or maintenance credits for accreditation purposes. Learn more about AIUM Ultrasound Practice Accreditation here.
ARRT Category A Credit
The AIUM is a Recognized Continuing Education Evaluation Mechanism (RCEEM) for the American Registry of Radiologic Technologists (ARRT). The AIUM is the owner and sponsor of this activity. This activity is approved by the AIUM for 1 ARRT Category A credit. This CE activity may be available in multiple formats or from different CE sponsors. ARRT does not allow CE activities (e.g., Internet courses, home study programs, directed readings, live lectures) to be repeated for CE credit in the same CE biennium.
Additional Credit Information
- American Registry for Diagnostic Medical Sonography (ARDMS). The ARDMS accepts AMA PRA Category 1 CME Credit(s)™.
Documenting CME Credits
All participants who pass the post-test with a score of at least 80% will have access to claim a CME certificate. The AIUM will submit credits to the ARDMS for active AIUM membership accounts with a valid ARDMS ID number. It is the participant’s responsibility to ensure credit accuracy and adherence to any audit requests.
Disclosure Policy:
In accordance with the Accreditation Council for Continuing Medical Education's (ACCME) Standards for Integrity and Independence in Accredited Continuing Education, the American Institute of Ultrasound Medicine (AIUM) requires those in control of educational content to disclose their financial relationships with ineligible companies* within the prior 24 months. Individuals must disclose all financial relationships with ineligible companies*, regardless of the amount and regardless of their view of the relevance of the relationship to the education. * Ineligible companies are defined by the ACCME as companies whose primary business is producing, marketing, selling, re-selling, or distributing health care products used by or on patients. For specific examples of ineligible companies, visit accme.org/standards.
As an accredited provider, AIUM must collect information from all planners, faculty and others in the planning and control of continuing medical education (CME) activities to disclose all of their financial relationships with ineligible companies within the prior 24 months. There is no minimum financial threshold; individuals must disclose all financial relationships, regardless of the amount, in ineligible companies. Individuals must disclose financial relationships with ineligible companies regardless of their view of the relevance of the relationship to the education.
AIUM has implemented a system to resolve conflicts of interest for each CME activity to help ensure content is objective, fair balanced, independent, and free of commercial bias. Conflicts, if any, are resolved through one or more processes. All relevant conflicts pertaining to this activity have been mitigated.
The following faculty/planners have disclosed the following financial relationships with ineligible companies:
Pengfei Song, PhD, panelist, Patent: Alpinion Medical Systems, GE HealthCare, Mindray, Samsung
Alycen Wiacek, PhD, panelist, Patent: CohereNet
The following faculty/planners of this educational activity have no relevant financial relationship(s) with ineligible companies to disclose.
Tommaso Di Ianni, PhD, faculty/planner, Charlotte Henningsen, MS, RT(R), clinical reviewer.
AIUM education planners and staff have no financial relationships with an ineligible company to disclose.
Tommaso Di Ianni, PhD
Assistant Professor Director, Basic Ultrasound Research Program Co-Director, Focused Ultrasound in Neuroscience Program Department of Psychiatry and Behavioral Sciences Department of Radiology and Biomedical Imaging Weill Institute for Neurosciences Unive
Program and co-Director of the UCSF Focused Ultrasound in Neuroscience Program. Dr. Di Ianni’s lab develops translational ultrasound technologies for neuroimaging and image-guided neurointervention. Before joining UCSF, he was a postdoctoral fellow at Stanford University, specializing in ultrasound neuromodulation, functional ultrasound imaging, and targeted drug delivery. He holds a PhD in biomedical engineering from the Technical University of Denmark and an MSc degree (summa cum laude) in electronic engineering from the University of Bologna, Italy. For his work, Dr. Di Ianni has received the NIH Stephen I. Katz Early-Stage Investigator award, the Stanford School of Medicine Dean’s Postdoctoral Fellowship, and the AIUM New Investigator Award.
